tyrosine has been researched along with Depressive Disorder, Major in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (35.29) | 29.6817 |
2010's | 7 (41.18) | 24.3611 |
2020's | 4 (23.53) | 2.80 |
Authors | Studies |
---|---|
Edwards, MJ; Gulbins, E; Keitsch, S; Kornhuber, J; Müller, CP; Soddemann, M; Wilker, B; Wilson, GC | 1 |
Edwards, MJ; Gulbins, E; Keitsch, S; Soddemann, M; Wilker, B; Wilson, GC | 1 |
Bekhbat, M; Felger, JC; Goldsmith, DR; Haroon, E; Miller, AH; Treadway, MT; Woolwine, BJ | 1 |
Fang, W; Huang, M; Li, J; Liu, X; Luo, J; Shi, X; Tang, YQ; Wang, XD; Xiao, L; Xu, J; Yang, W; Yuan, T; Zhang, Q; Zhang, Y | 1 |
Cohen, LS; Frey, BN; Gelain, DP; Harlow, BL; Minuzzi, L; Moreira, JCF; Otto, MW; Pasquali, MA; Soares, CN | 1 |
Chen, JJ; Dong, MX; Huang, T; Huang, YJ; Wang, MJ; Wang, Y; Xie, P; Zheng, P; Zhou, LK | 1 |
Andreazza, AC; Shao, L; Wang, JF; Young, LT | 1 |
Anttila, S; Huuhka, M; Illi, A; Kampman, O; Lehtimäki, T; Leinonen, E; Mononen, N; Setälä-Soikkeli, E; Viikki, M | 1 |
Bird, TD; Ghetti, B; Jayadev, S; Leverenz, JB; Mastrianni, JA; Montine, TJ; Nochlin, D; Poorkaj, P; Schellenberg, GD; Steinbart, EJ | 1 |
Achim, CL; Chana, G; Everall, IP; Soontornniyomkij, B; Soontornniyomkij, V; Tsuang, MT | 1 |
Ren, YP; Sa, M; Tang, AG; Xiao, LD; Ying, L | 1 |
Kurup, AR; Kurup, PA | 1 |
Kurup, PA; Kurup, RK | 1 |
Cowen, PJ; Mannie, ZN; McTavish, SF | 1 |
Joyce, PR; Luty, SE; Mulder, RT; Porter, RJ | 1 |
Henn, FA; Sartorius, A | 1 |
Bruijn, JA; Fekkes, D; Hoekstra, R; Mulder, PG; Pepplinkhuizen, L; van den Broek, WW | 1 |
2 trial(s) available for tyrosine and Depressive Disorder, Major
Article | Year |
---|---|
Tyrosine depletion does not cause depressive relapse in antidepressant-treated patients.
Topics: Adult; Amino Acids, Neutral; Antidepressive Agents, Tricyclic; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Middle Aged; Phenylalanine; Prolactin; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Tryptophan; Tyrosine | 2004 |
Tryptophan and tyrosine availability and response to antidepressant treatment in major depression.
Topics: Adrenergic Uptake Inhibitors; Adult; Amino Acids, Neutral; Antidepressive Agents, Tricyclic; Circadian Rhythm; Depressive Disorder, Major; Female; Fluoxetine; Follow-Up Studies; Humans; Hydrocortisone; Male; Nortriptyline; Prolactin; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Tryptophan; Tyrosine | 2005 |
15 other study(ies) available for tyrosine and Depressive Disorder, Major
Article | Year |
---|---|
Molecular targets of endothelial phosphatidic acid regulating major depressive disorder.
Topics: Animals; Ceramides; Depressive Disorder, Major; Endothelial Cells; Mice; Phosphatidic Acids; Phosphorylation; Tyrosine | 2022 |
Role of Tyrosine Nitrosylation in Stress-Induced Major Depressive Disorder: Mechanisms and Implications.
Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Fluoxetine; Glucocorticoids; Hippocampus; Mice; Tyrosine | 2023 |
Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia.
Topics: Anhedonia; C-Reactive Protein; Depression; Depressive Disorder, Major; Humans; Insulin Resistance; Phosphatidylinositol 3-Kinases; Tyrosine | 2020 |
Disrupting phosphorylation of Tyr-1070 at GluN2B selectively produces resilience to depression-like behaviors.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Depressive Disorder, Major; Hippocampus; Mice; Neurons; Receptors, N-Methyl-D-Aspartate; Synapses; Tyrosine | 2021 |
A longitudinal study of neurotrophic, oxidative, and inflammatory markers in first-onset depression in midlife women.
Topics: Adult; Brain-Derived Neurotrophic Factor; Cytokines; Depressive Disorder, Major; Female; HSP70 Heat-Shock Proteins; Humans; Inflammation; Lipid Peroxidation; Longitudinal Studies; Middle Aged; Oxidative Stress; Protein Carbamylation; Psychiatric Status Rating Scales; Surveys and Questionnaires; Thiobarbituric Acid Reactive Substances; Tyrosine | 2018 |
A novel urinary metabolite signature for diagnosing major depressive disorder.
Topics: Adult; Biomarkers; Case-Control Studies; Depressive Disorder, Major; Dicarboxylic Acids; Discriminant Analysis; Female; Gas Chromatography-Mass Spectrometry; Hippurates; Humans; Least-Squares Analysis; Male; Metabolome; Middle Aged; Niacinamide; Quinolinic Acid; ROC Curve; Sorbitol; Tyrosine; Uric Acid | 2013 |
Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder.
Topics: Adult; Aged; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder, Major; Electron Transport Complex I; Female; Humans; Male; Middle Aged; Mitochondrial Proteins; NADH Dehydrogenase; Oxidative Stress; Prefrontal Cortex; Schizophrenia; Tyrosine | 2010 |
P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT.
Topics: Adult; Aged; Arginine; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Glutamine; Histidine; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Purinergic P2X7; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Tyrosine | 2011 |
Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype.
Topics: Adult; Aged; Alzheimer Disease; Codon, Nonsense; Depressive Disorder, Major; Female; Glutamine; Humans; Memory Disorders; Memory, Short-Term; Middle Aged; Neurofibrillary Tangles; Neuropsychological Tests; Phenotype; Prion Diseases; Prion Proteins; Prions; tau Proteins; Tyrosine | 2011 |
Tyrosine kinase B protein expression is reduced in the cerebellum of patients with bipolar disorder.
Topics: Adult; Bipolar Disorder; Brain-Derived Neurotrophic Factor; Case-Control Studies; Cerebellum; Depressive Disorder, Major; Female; Hippocampus; Humans; Male; Middle Aged; Nerve Growth Factors; Neurons; Protein Isoforms; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Receptor, trkB; Schizophrenia; Signal Transduction; Tyrosine | 2011 |
Simultaneous determination of tyrosine, tryptophan and 5-hydroxytryptamine in serum of MDD patients by high performance liquid chromatography with fluorescence detection.
Topics: Adult; Blood Proteins; Calibration; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Female; Fluorescence; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Serotonin; Time Factors; Tryptophan; Tyrosine; Young Adult | 2012 |
Membrane Na(+)-K+ ATPase mediated cascade in bipolar mood disorder, major depressive disorder, and schizophrenia--relationship to hemispheric dominance.
Topics: Adult; Bipolar Disorder; Depressive Disorder, Major; Digoxin; Dominance, Cerebral; Humans; Hydroxymethylglutaryl CoA Reductases; Magnesium; Sampling Studies; Schizophrenia; Sodium-Potassium-Exchanging ATPase; Tryptophan; Tyrosine | 2002 |
Familial hypothalamic digoxin deficiency syndrome.
Topics: Body Mass Index; Brain Chemistry; Depressive Disorder, Major; Digoxin; Dolichols; Dominance, Cerebral; Erythrocytes; Family Health; Female; Glycosaminoglycans; Humans; Hydroxymethylglutaryl CoA Reductases; Hypertension; Hypothalamic Diseases; Male; Obsessive-Compulsive Disorder; Osteoporosis; Respiration Disorders; Sexual Dysfunction, Physiological; Sodium-Potassium-Exchanging ATPase; Tics; Tryptophan; Tyrosine | 2004 |
Deep brain stimulation of the lateral habenula in treatment resistant major depression.
Topics: Animals; Antidepressive Agents; Deep Brain Stimulation; Depression; Depressive Disorder, Major; Electric Stimulation; Electrophysiology; Habenula; Humans; Models, Theoretical; Positron-Emission Tomography; Serotonin; Synaptic Transmission; Tryptophan; Tyrosine | 2007 |
Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression.
Topics: Adult; Aged; Amino Acids, Neutral; Biopterins; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Isoleucine; Leucine; Male; Middle Aged; Neopterin; Phenylalanine; Psychiatric Status Rating Scales; Psychotic Disorders; Reference Values; Treatment Outcome; Tryptophan; Tyrosine; Valine | 2001 |